Average Co-Inventor Count = 4.70
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Wilex Ag (11 from 36 patents)
2. Wilex Biotechnology Gmbh (3 from 3 patents)
3. Max-planck-gesellschaft Zur Förderung Der Wissenschaften E. V. (2 from 1,289 patents)
4. Therawis Diagnostics Gmbh (1 from 2 patents)
15 patents:
1. 11230737 - Methods for assessing the treatment response of TNBC patients to neo-adjuvant chemotherapy by analysing CpG methylation
2. 10620208 - Classifying a cancer disease using CAIX expression
3. 7691375 - Adjuvant theraphy of G250-expressing tumors
4. 7399468 - Diagnostic and therapeutic use of antibodies against the urokinase receptor
5. 7342018 - Urokinase inhibitors and uses thereof
6. 7314863 - Cyclic peptidomimetic urokinase receptor antagonists
7. 7208521 - Selective inhibitors of the urokinase plasminogen activator
8. 7049344 - Highly selective inhibitors of the urokinase plasminogen activator
9. 7049460 - Selective inhibitors of the urokinase plasminogen activator
10. 7045504 - Cyclic peptidomimetic urokinase receptor antagonists
11. 6906032 - Cyclic peptidomimetic urokinase receptor antagonists
12. 6872702 - Inhibitors for urokinase receptor
13. 6841702 - Highly selective inhibitors of the urokinase plasminogen activator
14. 6680320 - Urokinase inhibitors
15. 6624169 - Urokinase inhibitors